Platinum Investment Management LTD Agios Pharmaceuticals, Inc. Transaction History

Platinum Investment Management LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$41.92 - $58.18 $2.37 Million - $3.29 Million	-56,593 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$44.23 - $57.5 $537,792 - $699,142	-12,159 Reduced 17.69%	56,593 $2.92 Million
Q1 2020 May 15, 2020	BUY	$31.52 - $53.81 $230,663 - $393,781	7,318 Added 11.91%	68,752 $2.44 Million
Q4 2019 Feb 13, 2020	BUY	$30.08 - $50.59 $311,358 - $523,657	10,351 Added 20.26%	61,434 $2.93 Million
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $442,162 - $676,618	13,647 Added 36.45%	51,083 $1.66 Million
Q4 2018 Feb 14, 2019	BUY	$42.73 - $76.53 $309,194 - $553,771	7,236 Added 23.96%	37,436 $1.73 Million
Q1 2018 May 15, 2018	SELL	$59.83 - $86.53 $335,048 - $484,568	-5,600 Reduced 15.64%	30,200 $2.47 Million
Q2 2017 Aug 15, 2017	BUY	N/A	35,800	35,800 $1.84 Million

231

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.85B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.